Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

irbesartan-hydroCHLOROthiazide

irbesartan-hydroCHLOROthiazide
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Avalide TABLET, ORAL 150 mg-12.5 mg, 300 mg-12.5 mg, 300 mg-25 mg    
VIEW MORE Angiotensin II Receptor Antagonists, Thiazide Diuretics
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

irbesartan-hydroCHLOROthiazide (Avalide)

  • 150 mg-12.5 mg tablet oral Daily
  • 300 mg-12.5 mg tablet oral Daily
  • 300 mg-25 mg tablet oral Daily

losartan-hydroCHLOROthiazide (Hyzaar)

  • 50 mg-12.5 mg tablet oral Daily
  • 100 mg-12.5 mg tablet oral Daily
  • 100 mg-25 mg tablet oral Daily

 

Reviewed: April 27, 2010.

Last updated: Oct. 25, 2023






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved